Skip to main content
Erschienen in: Neurological Sciences 11/2020

30.04.2020 | Original Article

Evidence of retinal anterograde neurodegeneration in the very early stages of multiple sclerosis: a longitudinal OCT study

verfasst von: Anna M. Pietroboni, Tiziana Carandini, Laura Dell’Arti, Francesca Bovis, Annalisa Colombi, Milena A. De Riz, Elena Casazza, Elisa Scola, Chiara Fenoglio, Andrea Arighi, Giorgio G. Fumagalli, Fabio Triulzi, Daniela Galimberti, Francesco Viola, Elio Scarpini

Erschienen in: Neurological Sciences | Ausgabe 11/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Neurodegenerative processes are present since the early stages of multiple sclerosis (MS), constituting the primary substrate of disability. As part of the CNS, retinal damage could be considered a reliable prognostic biomarker of neurodegeneration in MS.

Objectives

To characterize longitudinal changes in the retinal layers’ thickness and to investigate correlations between retinal atrophy and other prognostic biomarkers, i.e., cerebrospinal fluid (CSF) β-amyloid1–42 (Aβ) levels.

Methods

Forty-two eyes without a history of optic neuritis of 23 MS patients were recruited. All patients underwent spectral-domain-OCT scans (SD-OCT), brain magnetic resonance imaging (MRI), and lumbar puncture at baseline. SD-OCT and brain MRI were repeated after 12 months. Ten controls underwent the same OCT procedure.

Results

At baseline, macular ganglion cell/inner plexiform layer (mGCIPL) thickness was reduced in patients compared to controls (p = 0.008), without retinal nerve fiber layer (RNFL) thinning, that was revealed only at follow-up (p = 0.005). Patients with lower CSF Aβ levels displayed reduced RNFL thickness values, both at baseline and follow-up.

Conclusions

At very early clinical stages, mGCIPL thickness values were reduced without a concomitant peripapillary RNFL thinning. The longitudinal assessment demonstrated a RNFL loss in patients compared to HC, together with a plateau of mGCIPL thinning. Aβlow subgroup of patients showed a reduction of retinal nerve fiber layer thickness.
Literatur
1.
Zurück zum Zitat Wallin MT, Culpepper WJ, Nichols E, Bhutta ZA, Gebrehiwot TT, Hay SI, Khalil IA, Krohn KJ, Liang X, Naghavi M, Mokdad AH, Nixon MR, Reiner RC, Sartorius B, Smith M, Topor-Madry R, Werdecker A, Vos T, Feigin VL, Murray CJL (2019) Global, regional, and national burden of multiple sclerosis 1990–2016: a systematic analysis for the Global Burden of Disease Study. Lancet Neurol Wallin MT, Culpepper WJ, Nichols E, Bhutta ZA, Gebrehiwot TT, Hay SI, Khalil IA, Krohn KJ, Liang X, Naghavi M, Mokdad AH, Nixon MR, Reiner RC, Sartorius B, Smith M, Topor-Madry R, Werdecker A, Vos T, Feigin VL, Murray CJL (2019) Global, regional, and national burden of multiple sclerosis 1990–2016: a systematic analysis for the Global Burden of Disease Study. Lancet Neurol
2.
Zurück zum Zitat Friese MA, Schattling B, Fugger L (2014) Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis. Nat Rev Neurol 10(4):225–238PubMedCrossRef Friese MA, Schattling B, Fugger L (2014) Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis. Nat Rev Neurol 10(4):225–238PubMedCrossRef
4.
Zurück zum Zitat Lassmann H (2018) Pathogenic mechanisms associated with different clinical courses of multiple sclerosis. Front Immunol 9:3116PubMedCrossRef Lassmann H (2018) Pathogenic mechanisms associated with different clinical courses of multiple sclerosis. Front Immunol 9:3116PubMedCrossRef
5.
Zurück zum Zitat Bjartmar C, Trapp BD (2001) Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences. Curr Opin Neurol 14(3):271–278PubMedCrossRef Bjartmar C, Trapp BD (2001) Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences. Curr Opin Neurol 14(3):271–278PubMedCrossRef
6.
Zurück zum Zitat Frischer JM, Bramow S, Dal-Bianco A, Lucchinetti CF, Rauschka H, Schmidbauer M, Laursen H, Sorensen PS, Lassmann H (2009) The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 132(5):1175–1189PubMedPubMedCentralCrossRef Frischer JM, Bramow S, Dal-Bianco A, Lucchinetti CF, Rauschka H, Schmidbauer M, Laursen H, Sorensen PS, Lassmann H (2009) The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 132(5):1175–1189PubMedPubMedCentralCrossRef
7.
Zurück zum Zitat Petzold A. (2018) Neurodegeneration and multiple sclerosis. In: NeurodegeneratIve Diseases: Clinical Aspects, Molecular Genetics and Biomarkers.; 379–400 Petzold A. (2018) Neurodegeneration and multiple sclerosis. In: NeurodegeneratIve Diseases: Clinical Aspects, Molecular Genetics and Biomarkers.; 379–400
8.
Zurück zum Zitat Balk LJ, Cruz-Herranz A, Albrecht P, Arnow S, Gelfand JM, Tewarie P, Killestein J, Uitdehaag BMJ, Petzold A, Green AJ (2016) Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study. J Neurol 263(7):1323–1331PubMedPubMedCentralCrossRef Balk LJ, Cruz-Herranz A, Albrecht P, Arnow S, Gelfand JM, Tewarie P, Killestein J, Uitdehaag BMJ, Petzold A, Green AJ (2016) Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study. J Neurol 263(7):1323–1331PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Costello F (2013) The afferent visual pathway: designing a structural-functional paradigm of multiple sclerosis. ISRN Neurol 2013:1–17CrossRef Costello F (2013) The afferent visual pathway: designing a structural-functional paradigm of multiple sclerosis. ISRN Neurol 2013:1–17CrossRef
11.
Zurück zum Zitat Frohman EM, Fujimoto JG, Frohman TC, Calabresi PA, Cutter G, Balcer LJ (2008) Optical coherence tomography: a window into the mechanisms of multiple sclerosis. Nat Clin Pract Neurol 4(12):664–675PubMedPubMedCentralCrossRef Frohman EM, Fujimoto JG, Frohman TC, Calabresi PA, Cutter G, Balcer LJ (2008) Optical coherence tomography: a window into the mechanisms of multiple sclerosis. Nat Clin Pract Neurol 4(12):664–675PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat Petzold A, Balcer L, Calabresi PA et al (2017) Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol 16(10):797–812PubMedCrossRef Petzold A, Balcer L, Calabresi PA et al (2017) Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol 16(10):797–812PubMedCrossRef
13.
Zurück zum Zitat Petzold A, de Boer JF, Schippling S, Vermersch P, Kardon R, Green A, Calabresi PA, Polman C (2010) Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol 9(9):921–932PubMedCrossRef Petzold A, de Boer JF, Schippling S, Vermersch P, Kardon R, Green A, Calabresi PA, Polman C (2010) Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol 9(9):921–932PubMedCrossRef
14.
Zurück zum Zitat Fisher JB, Jacobs DA, Markowitz CE, Galetta SL, Volpe NJ, Nano-Schiavi ML, Baier ML, Frohman EM, Winslow H, Frohman TC, Calabresi PA, Maguire MG, Cutter GR, Balcer LJ (2006) Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology. 113(2):324–332PubMedCrossRef Fisher JB, Jacobs DA, Markowitz CE, Galetta SL, Volpe NJ, Nano-Schiavi ML, Baier ML, Frohman EM, Winslow H, Frohman TC, Calabresi PA, Maguire MG, Cutter GR, Balcer LJ (2006) Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology. 113(2):324–332PubMedCrossRef
15.
Zurück zum Zitat Martinez-Lapiscina EH, Arnow S, Wilson JA, Saidha S, Preiningerova JL, Oberwahrenbrock T, Brandt AU, Pablo LE, Guerrieri S, Gonzalez I, Outteryck O, Mueller AK, Albrecht P, Chan W, Lukas S, Balk LJ, Fraser C, Frederiksen JL, Resto J, Frohman T, Cordano C, Zubizarreta I, Andorra M, Sanchez-Dalmau B, Saiz A, Bermel R, Klistorner A, Petzold A, Schippling S, Costello F, Aktas O, Vermersch P, Oreja-Guevara C, Comi G, Leocani L, Garcia-Martin E, Paul F, Havrdova E, Frohman E, Balcer LJ, Green AJ, Calabresi PA, Villoslada P, IMSVISUAL consortium (2016) Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study. Lancet Neurol 15(6):574–584PubMedCrossRef Martinez-Lapiscina EH, Arnow S, Wilson JA, Saidha S, Preiningerova JL, Oberwahrenbrock T, Brandt AU, Pablo LE, Guerrieri S, Gonzalez I, Outteryck O, Mueller AK, Albrecht P, Chan W, Lukas S, Balk LJ, Fraser C, Frederiksen JL, Resto J, Frohman T, Cordano C, Zubizarreta I, Andorra M, Sanchez-Dalmau B, Saiz A, Bermel R, Klistorner A, Petzold A, Schippling S, Costello F, Aktas O, Vermersch P, Oreja-Guevara C, Comi G, Leocani L, Garcia-Martin E, Paul F, Havrdova E, Frohman E, Balcer LJ, Green AJ, Calabresi PA, Villoslada P, IMSVISUAL consortium (2016) Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study. Lancet Neurol 15(6):574–584PubMedCrossRef
16.
Zurück zum Zitat Gordon-Lipkin E, Chodkowski B, Reich DS, Smith SA, Pulicken M, Balcer LJ, Frohman EM, Cutter G, Calabresi PA (2007) Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology. 69(16):1603–1609PubMedCrossRef Gordon-Lipkin E, Chodkowski B, Reich DS, Smith SA, Pulicken M, Balcer LJ, Frohman EM, Cutter G, Calabresi PA (2007) Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology. 69(16):1603–1609PubMedCrossRef
17.
Zurück zum Zitat Saidha S, Al-Louzi O, Ratchford JN et al (2015) Optical coherence tomography reflects brain atrophy in multiple sclerosis: a four-year study. Ann Neurol 78(5):801–813PubMedPubMedCentralCrossRef Saidha S, Al-Louzi O, Ratchford JN et al (2015) Optical coherence tomography reflects brain atrophy in multiple sclerosis: a four-year study. Ann Neurol 78(5):801–813PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Saidha S, Sotirchos ES, Ibrahim MA, Crainiceanu CM, Gelfand JM, Sepah YJ, Ratchford JN, Oh J, Seigo MA, Newsome SD, Balcer LJ, Frohman EM, Green AJ, Nguyen QD, Calabresi PA (2012) Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study. Lancet Neurol 11(11):963–972PubMedPubMedCentralCrossRef Saidha S, Sotirchos ES, Ibrahim MA, Crainiceanu CM, Gelfand JM, Sepah YJ, Ratchford JN, Oh J, Seigo MA, Newsome SD, Balcer LJ, Frohman EM, Green AJ, Nguyen QD, Calabresi PA (2012) Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study. Lancet Neurol 11(11):963–972PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat Gelfand JM, Nolan R, Schwartz DM, Graves J, Green AJ (2012) Microcystic macular oedema in multiple sclerosis is associated with disease severity. Brain. 135(6):1786–1793PubMedPubMedCentralCrossRef Gelfand JM, Nolan R, Schwartz DM, Graves J, Green AJ (2012) Microcystic macular oedema in multiple sclerosis is associated with disease severity. Brain. 135(6):1786–1793PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Sepulcre J, Murie-Fernandez M, Salinas-Alaman A, Garcia-Layana A, Bejarano B, Villoslada P (2007) Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS. Neurology. 68(18):1488–1494PubMedCrossRef Sepulcre J, Murie-Fernandez M, Salinas-Alaman A, Garcia-Layana A, Bejarano B, Villoslada P (2007) Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS. Neurology. 68(18):1488–1494PubMedCrossRef
21.
Zurück zum Zitat Ratchford JN, Saidha S, Sotirchos ES, Oh JA, Seigo MA, Eckstein C, Durbin MK, Oakley JD, Meyer SA, Conger A, Frohman TC, Newsome SD, Balcer LJ, Frohman EM, Calabresi PA (2013) Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning. Neurology. 80(1):47–54PubMedPubMedCentralCrossRef Ratchford JN, Saidha S, Sotirchos ES, Oh JA, Seigo MA, Eckstein C, Durbin MK, Oakley JD, Meyer SA, Conger A, Frohman TC, Newsome SD, Balcer LJ, Frohman EM, Calabresi PA (2013) Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning. Neurology. 80(1):47–54PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat Pisa M, Guerrieri S, Di Maggio G et al (2017) No evidence of disease activity is associated with reduced rate of axonal retinal atrophy in MS. Neurology. 89(24):2469–2475PubMedCrossRef Pisa M, Guerrieri S, Di Maggio G et al (2017) No evidence of disease activity is associated with reduced rate of axonal retinal atrophy in MS. Neurology. 89(24):2469–2475PubMedCrossRef
23.
Zurück zum Zitat Talman LS, Bisker ER, Sackel DJ, Long da Jr, Galetta KM, Ratchford JN, Lile DJ, Farrell SK, Loguidice MJ, Remington G, Conger A, Frohman TC, Jacobs DA, Markowitz CE, Cutter GR, Ying GS, Dai Y, Maguire MG, Galetta SL, Frohman EM, Calabresi PA, Balcer LJ (2010) Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis. Ann Neurol 67(6):749–760PubMedPubMedCentral Talman LS, Bisker ER, Sackel DJ, Long da Jr, Galetta KM, Ratchford JN, Lile DJ, Farrell SK, Loguidice MJ, Remington G, Conger A, Frohman TC, Jacobs DA, Markowitz CE, Cutter GR, Ying GS, Dai Y, Maguire MG, Galetta SL, Frohman EM, Calabresi PA, Balcer LJ (2010) Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis. Ann Neurol 67(6):749–760PubMedPubMedCentral
24.
Zurück zum Zitat Garcia-Martin E, Pueyo V, Almarcegui C, Martin J, Ara JR, Sancho E, Pablo LE, Dolz I, Fernandez J (2011) Risk factors for progressive axonal degeneration of the retinal nerve fibre layer in multiple sclerosis patients. Br J Ophthalmol 95(11):1577–1582PubMedCrossRef Garcia-Martin E, Pueyo V, Almarcegui C, Martin J, Ara JR, Sancho E, Pablo LE, Dolz I, Fernandez J (2011) Risk factors for progressive axonal degeneration of the retinal nerve fibre layer in multiple sclerosis patients. Br J Ophthalmol 95(11):1577–1582PubMedCrossRef
25.
Zurück zum Zitat Gabilondo I, Sanchez-Dalmau B, Berenguer J et al (2013) Trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis. Ann Neurol 75(1):98–107CrossRef Gabilondo I, Sanchez-Dalmau B, Berenguer J et al (2013) Trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis. Ann Neurol 75(1):98–107CrossRef
26.
Zurück zum Zitat Geurts JJG, Bö L, Pouwels PJW et al (2005) Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. Am J Neuroradiol 26(3):572–577PubMed Geurts JJG, Bö L, Pouwels PJW et al (2005) Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. Am J Neuroradiol 26(3):572–577PubMed
27.
Zurück zum Zitat Calabrese M, Atzori M, Bernardi V, Morra A, Romualdi C, Rinaldi L, McAuliffe MJM, Barachino L, Perini P, Fischl B, Battistin L, Gallo P (2007) Cortical atrophy is relevant in multiple sclerosis at clinical onset. J Neurol 254(9):1212–1220PubMedCrossRef Calabrese M, Atzori M, Bernardi V, Morra A, Romualdi C, Rinaldi L, McAuliffe MJM, Barachino L, Perini P, Fischl B, Battistin L, Gallo P (2007) Cortical atrophy is relevant in multiple sclerosis at clinical onset. J Neurol 254(9):1212–1220PubMedCrossRef
28.
Zurück zum Zitat Green AJ, McQuaid S, Hauser SL, Allen IV, Lyness R (2010) Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. Brain. 133(6):1591–1601PubMedPubMedCentralCrossRef Green AJ, McQuaid S, Hauser SL, Allen IV, Lyness R (2010) Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. Brain. 133(6):1591–1601PubMedPubMedCentralCrossRef
29.
Zurück zum Zitat Saidha S, Syc SB, Durbin MK, Eckstein C, Oakley JD, Meyer SA, Conger A, Frohman TC, Newsome S, Ratchford JN, Frohman EM, Calabresi PA (2011) Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness. Mult Scler J 17(12):1449–1463CrossRef Saidha S, Syc SB, Durbin MK, Eckstein C, Oakley JD, Meyer SA, Conger A, Frohman TC, Newsome S, Ratchford JN, Frohman EM, Calabresi PA (2011) Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness. Mult Scler J 17(12):1449–1463CrossRef
30.
Zurück zum Zitat Pietroboni AM, Dell’Arti L, Caprioli M, Scarioni M, Carandini T, Arighi A, Ghezzi L, Fumagalli GG, de Riz MA, Basilico P, Colombi A, Benatti E, Triulzi F, Scarpini E, Viola F, Galimberti D (2019) The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients. Mult Scler J 25(1):31–38CrossRef Pietroboni AM, Dell’Arti L, Caprioli M, Scarioni M, Carandini T, Arighi A, Ghezzi L, Fumagalli GG, de Riz MA, Basilico P, Colombi A, Benatti E, Triulzi F, Scarpini E, Viola F, Galimberti D (2019) The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients. Mult Scler J 25(1):31–38CrossRef
31.
Zurück zum Zitat Pietroboni AM, Schiano Di Cola F, Scarioni M et al (2017) CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis. Mult Scler 23(8):1085–1091PubMedCrossRef Pietroboni AM, Schiano Di Cola F, Scarioni M et al (2017) CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis. Mult Scler 23(8):1085–1091PubMedCrossRef
32.
Zurück zum Zitat Pietroboni AM, Caprioli M, Carandini T, et al. (2018) CSF β-amyloid predicts prognosis in patients with multiple sclerosis. Mult Scler J 135245851879170 Pietroboni AM, Caprioli M, Carandini T, et al. (2018) CSF β-amyloid predicts prognosis in patients with multiple sclerosis. Mult Scler J 135245851879170
33.
Zurück zum Zitat Pietroboni AM, Carandini T, Colombi A, Mercurio M, Ghezzi L, Giulietti G, Scarioni M, Arighi A, Fenoglio C, de Riz MA, Fumagalli GG, Basilico P, Serpente M, Bozzali M, Scarpini E, Galimberti D, Marotta G (2019) Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes. Eur J Nucl Med Mol Imaging 46(2):280–287PubMedCrossRef Pietroboni AM, Carandini T, Colombi A, Mercurio M, Ghezzi L, Giulietti G, Scarioni M, Arighi A, Fenoglio C, de Riz MA, Fumagalli GG, Basilico P, Serpente M, Bozzali M, Scarpini E, Galimberti D, Marotta G (2019) Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes. Eur J Nucl Med Mol Imaging 46(2):280–287PubMedCrossRef
34.
Zurück zum Zitat Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol
35.
Zurück zum Zitat Graham EC, You Y, Yiannikas C, Garrick R, Parratt J, Barnett MH, Klistorner A (2016) Progressive loss of retinal ganglion cells and axons in nonoptic neuritis eyes in multiple sclerosis: a longitudinal optical coherence tomography study. Invest Ophthalmol Vis Sci 57(4):2311–2317PubMedCrossRef Graham EC, You Y, Yiannikas C, Garrick R, Parratt J, Barnett MH, Klistorner A (2016) Progressive loss of retinal ganglion cells and axons in nonoptic neuritis eyes in multiple sclerosis: a longitudinal optical coherence tomography study. Invest Ophthalmol Vis Sci 57(4):2311–2317PubMedCrossRef
Metadaten
Titel
Evidence of retinal anterograde neurodegeneration in the very early stages of multiple sclerosis: a longitudinal OCT study
verfasst von
Anna M. Pietroboni
Tiziana Carandini
Laura Dell’Arti
Francesca Bovis
Annalisa Colombi
Milena A. De Riz
Elena Casazza
Elisa Scola
Chiara Fenoglio
Andrea Arighi
Giorgio G. Fumagalli
Fabio Triulzi
Daniela Galimberti
Francesco Viola
Elio Scarpini
Publikationsdatum
30.04.2020
Verlag
Springer International Publishing
Erschienen in
Neurological Sciences / Ausgabe 11/2020
Print ISSN: 1590-1874
Elektronische ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-020-04431-4

Weitere Artikel der Ausgabe 11/2020

Neurological Sciences 11/2020 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.